Jr. Gnarra et al., DEFECTIVE PLACENTAL VASCULOGENESIS CAUSES EMBRYONIC LETHALITY IN VHL-DEFICIENT MICE, Proceedings of the National Academy of Sciences of the United Statesof America, 94(17), 1997, pp. 9102-9107
Inheritance of an inactivated form of the VHL tumor suppressor gene pr
edisposes patients to develop von Hippel-Lindau disease, and somatic V
HL inactivation is an early genetic event leading to the development o
f sporadic renal cell carcinoma, The VHL gene was disrupted by targete
d homologous recombination in murine embryonic stem cells, and a mouse
line containing an inactivated VHL allele was generated, While hetero
zygous VHL (+/-) mice appeared phenotypically normal, VHL -/- mice die
d in utero at 10.5 to 12.5 days of gestation (E10.5 to E12.5). Homozyg
ous VHL -/- embryos appeared to develop normally until E9.5 to E10.5,
when placental dysgenesis developed, Embryonic vasculogenesis of the p
lacenta failed to occur in VHL -/- mice, and hemorrhagic lesions devel
oped in the placenta, Subsequent hemorrhage in VHL -/- embryos caused
necrosis and death, These results indicate that VHL expression is crit
ical for normal extraembryonic vascular development.